Liceaga-Escalera CJ, Montoya-Pérez LA, González-Ángulo VH, Jiménez-De La Puente G

Language: Spanish
References: 16
Page: 96-100
PDF size: 196.24 Kb.

ABSTRACT

Introduction: The giant cell giant lesion, formerly called giant cell granuloma, is an entity of idiopathic origin, two variants are described; aggressive and non-aggressive, based on their biological behavior. The aim of presenting this case is to review current concepts of this entity and to give the importance of the use of the CD34 immunomarker, to establish a conservative treatment and to prevent functional aesthetic sequelae. Clinical case: An 8-year-old female presented with a condition of two months of evolution, characterized by a bulge in the middle third of the right side of the face, the intraoral examination showed a well-defined volume increase in the right upper quadrant, red color, firm consistency, circular shape and not painful to the palpation, in the orthopantomography a poorly delimited radiolucent image was seen in the upper right quadrant region, related to the right upper canine, the histopathological report concluded with a central lesion of giant cells, the immunomarker CD34 was positive in 2%, the treatment was enucleation and curettage of the lesion, with no recurrence after three years of follow-up. Conclusion: The central lesion of giant cells is a widely known entity and the therapeutic behavior can be performed conservatively, as long as it can be demonstrated by molecular subtype that it is a non-aggressive variant.

REFERENCES

1. Kaffe I, Ardekian L, Taicher S, Littner MM, Buchner A. Radiologic features of central giant cell granuloma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81(6): 720-6.

2. Jaffe HL. Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-osseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol 1953; 6(1): 159-75.

3. Giri GV, Sukumaran G, Ravindran C, Narasimman M. Giant cell tumor of the mandible. J Oral Maxillofac Pathol 2015; 19(1): 108.

4. Ferretti C, Muthray E. Management of central giant cell granuloma of mandible using intralesional corticosteroids: case report and review of literature. J Oral Maxillofac Surg 2011; 69(11): 2824-9.

5. Sauter GJ. Central giant cell lesion. In: Barnes L EJRPSD, editor. Pathology and genetics of head and neck tumors. Lyon: IARC; 2005. p. 324.

6. Rachmiel A, Emodi O, Sabo E, Aizembud D, Peled M. Combined treatment of aggressive central giant cell granuloma on the lower jaw. J Craneomaxillofac Surg 2012; 40(3): 292-7.

7. Nogueira RL, Faria MH, Osterne RL, Cavalcante RB, Ribeiro RA, Rabenhorst SH. Glucocorticoid and calcitonin receptor expression in central giant cell lesions: implications for therapy. Int J Oral Maxillofac Surg 2012; 41(8): 994-1000.

8. El-Naggar AK, Chan J, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumors. 4th edition. Lion, France: 2017.

9. Pinheiro da Rosa MR, de Sá JL, Martins VB, de Olivera MV. Central giant cell lesion: report of a conservative managment. Eur J Dent 2018; 12(2): 305-10.

10. David J, Maximilian M, Reza M, Mukund D. Central giant cell granuloma of the mandible requiring multiple treatment modalities: a case report. J Maxillofac Surg 2016; 74(8): 1596-607.

11. Garg P, Jain J, De N, Chatterjee K. A central cell granuloma in posterior part of the maxilla- A case report. Int J Surg Case Rep 2017; 30: 222-5.

12. Zachary SP. Controversies in oral and maxillofacial pathology. Oral and Maxillofacial Surgery Clinics 2017; 29(4): 475-86.

13. Renato MN, Rafael LV, Roberta BC, Ricardo TA. Surgical treatment, oral rehabilitation, and orthognatic surgery after failure of pharmacologic treatment of central giant cell lesion: a case report. J Maxillofac Surg 2016; 74(12): 2567.

14. Melville JC, Couey MA, Tong MS, Marx RE. Regeneration of a tooth in a tissue-engineered mandible after resection of a central giant cell tumor. Demostrating evidence of funcional matrix theory and ectodermal origin of teeth in a human model- a case report. J Oral Maxillofac Surg 2017; 75(4): 850-7.

15. Bredell M, Rordorf T, Kroiss S, Rücker M, Zweifel DF, Rostetter C. Denosumab as a treatment alternative for central giant cell granuloma: a long-term retrospective cohort study. J Oral Maxillofac Surg 2018; 76(4): 775-84.

16. Schreuder WH, Peacock ZS, Ebb D, Chuang SK, Kaban LB. Adjuvant antiangiogenic treatment for aggressive giant cell lesions of the jaw: a 20-year experience at Massachusetts General Hospital. J Oral Maxillofac Surg 2017; 75(1): 105-18.